全球科技经济瞭望
全毬科技經濟瞭望
전구과기경제료망
QUANQIU KEJI JINGJI LIAOWANG
2014年
8期
19-26
,共8页
新西兰%研发支出%统计分析
新西蘭%研髮支齣%統計分析
신서란%연발지출%통계분석
New Zealand%R&D expenditure%statistics analysis
近年来,新西兰全社会研发投入呈增长态势。2013年8月,新西兰发布了《研发调查报告(2012)》。2012年,新西兰研发支出为26.25亿新元,占GDP的比重为1.27%,但在OECD国家中,比例偏低;研发经费主要来源企业、政府、高等院校、海外机构和其他群体,其中,政府和企业超过总投入的80%;研发活动分为基础研究、应用研究和实验开发三大类,其中,应用研究支出首次超过10亿新元,占全部研发支出的41%;制造业研发支出列首位,占总支出的20%;政府在生命科学研发支出中,占比最大;研发人员规模呈现持续增长态势。在新西兰,研发是企业进入市场的立足点,人员交流是建立联系的最主要途径。
近年來,新西蘭全社會研髮投入呈增長態勢。2013年8月,新西蘭髮佈瞭《研髮調查報告(2012)》。2012年,新西蘭研髮支齣為26.25億新元,佔GDP的比重為1.27%,但在OECD國傢中,比例偏低;研髮經費主要來源企業、政府、高等院校、海外機構和其他群體,其中,政府和企業超過總投入的80%;研髮活動分為基礎研究、應用研究和實驗開髮三大類,其中,應用研究支齣首次超過10億新元,佔全部研髮支齣的41%;製造業研髮支齣列首位,佔總支齣的20%;政府在生命科學研髮支齣中,佔比最大;研髮人員規模呈現持續增長態勢。在新西蘭,研髮是企業進入市場的立足點,人員交流是建立聯繫的最主要途徑。
근년래,신서란전사회연발투입정증장태세。2013년8월,신서란발포료《연발조사보고(2012)》。2012년,신서란연발지출위26.25억신원,점GDP적비중위1.27%,단재OECD국가중,비례편저;연발경비주요래원기업、정부、고등원교、해외궤구화기타군체,기중,정부화기업초과총투입적80%;연발활동분위기출연구、응용연구화실험개발삼대류,기중,응용연구지출수차초과10억신원,점전부연발지출적41%;제조업연발지출렬수위,점총지출적20%;정부재생명과학연발지출중,점비최대;연발인원규모정현지속증장태세。재신서란,연발시기업진입시장적립족점,인원교류시건립련계적최주요도경。
The total investment in research and development (R&D) in New Zealand has shown an increasing trend in recent years. In August 2013, New Zealand Government released the report of Research&Development Survey in New Zealand: 2012. The report indicates that in 2012 the R&D expenditure of New Zealand was up to NZD 2.625 billion, accounting for 1.27 percent of its GDP. This proportion is relatively low compared with other OECD countries. Its R&D funds come from businesses, government, universities, overseas organizations and other groups, of which businesses and government contribute over 80%of the total. The research activity is split into three types: basic research, applied research and experimental development. Expenditure on applied research showed the largest increase, exceeding 1 billion NZD for the first time and making up 41%of total R&D expenditure. Manufacture is the top area of economy to which the R&D is targeted, 20 percent of total R&D expenditure is for manufacturing purposes. Government sector continues to spend the most on bioscience R&D. The scale of R&D personnel has showed a consistent increasing trend since 2006. In New Zealand, R&D is a foothold into markets, and the most common way of engagement is between staffs.